WallStreetZenWallStreetZen

NASDAQ: DVAX
Dynavax Technologies Corp Earnings & Revenue

OverviewForecastEarnings
DividendOwnership

DVAX past revenue growth

How has DVAX's revenue growth performed historically?
Company
-67.86%
Industry
10.23%
Market
16.96%
DVAX's revenue has grown faster... subscribe to Premium to read more.
Revenue Growth vs Industry Performance
DVAX's revenue has grown faster... subscribe to Premium to read more.
Revenue Growth vs Market Performance
DVAX's revenue growth is slowing... subscribe to Premium to read more.
Accelerating Revenue Growth Performance

DVAX earnings and revenue history

Current Revenue
$232.3M
Current Earnings
-$6.4M
Current Profit Margin
-2.8%

DVAX Return on Equity

Current Company
-1.1%
Current Industry
15.4%
Current Market
188%
DVAX's Return on Equity (-1.1%)... subscribe to Premium to read more.
High Return on Equity Performance

Be the first to know when DVAX announces earnings.

DVAX Return on Assets

Current Company
-0.7%
Current Industry
3.4%
DVAX is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

DVAX Return on Capital Employed

Current Company
0.26%
Current Industry
5.1%
DVAX has gotten more efficient... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

DVAX vs Pharmaceutical Stocks

TickerRevenueEBITDAEarningsY/Y RevenueY/Y Earnings
DVAX$232.28M$9.67M-$6.39M+95.19%N/A
TLRY$743.25M-$186.62M-$351.95M+30.54%N/A
TARO$610.83MN/A$45.70M-1.69%-31.12%
AVDL$27.96M-$149.13M-$160.28M-22.99%N/A
ANIP$486.82M$107.87M$17.15M+19.28%-8.07%
View Top Pharmaceutical Stocks

DVAX earnings dates

Next earnings date
Apr 30, 2024

Dynavax Technologies Earnings & Revenue FAQ

What were DVAX's earnings last quarter?

On Invalid Date, Dynavax Technologies (NASDAQ: DVAX) reported Q4 2023 earnings per share (EPS) of $0.00, up 100% year over year. Total Dynavax Technologies earnings for the quarter were $219.00 thousand. In the same quarter last year, Dynavax Technologies's earnings per share (EPS) was $0.53.

If you're new to stock investing, here's how to buy Dynavax Technologies stock.

What was DVAX's earnings growth in the past year?

As of Q2 2024, Dynavax Technologies's earnings has grown year over year. Dynavax Technologies's earnings in the past year totalled -$6.39 million.

What is DVAX's earnings date?

Dynavax Technologies's earnings date is Invalid Date. Add DVAX to your watchlist to be reminded of DVAX's next earnings announcement.

What was DVAX's revenue last quarter?

On Invalid Date, Dynavax Technologies (NASDAQ: DVAX) reported Q4 2023 revenue of $55.60 million up 69.87% year over year. In the same quarter last year, Dynavax Technologies's revenue was $184.49 million.

What was DVAX's revenue growth in the past year?

As of Q2 2024, Dynavax Technologies's revenue has grown -67.86% year over year. This is 78.08 percentage points lower than the US Drug Manufacturers - Specialty & Generic industry revenue growth rate of 10.23%. Dynavax Technologies's revenue in the past year totalled $232.28 million.
©2024 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.